COMMUNIQUÉS West-GlobeNewswire

Bavarian Nordic A/S - Articles of Association

05/01/2018 - 14:23

Updated Articles of Association for Bavarian Nordic A/S Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/899513cf-91d6-4ada-a6ca-a627649f9371

Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)

05/01/2018 - 14:05

TUSTIN, Calif., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM ) (NASDAQ: PPHMP ), a company working to improve patient lives by providing high quality biologics manufacturing services [...]

Vital Therapies Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

05/01/2018 - 14:01

SAN DIEGO, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL ), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today reported [...]

Momenta Pharmaceuticals Reports Positive Top-Line Phase 1 Data Showing Proof of Mechanism for M281, an Anti-FcRn Monoclonal Antibody, in Healthy Volunteers

05/01/2018 - 14:00

CAMBRIDGE, Mass., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA ), a biotechnology company specializing in the characterization and engineering of complex drugs, today reported positive [...]

BeyondSpring to Present at the 10th Annual Biotech Showcase

05/01/2018 - 14:00

NEW YORK, Jan. 05, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ) (“BeyondSpring” or the “Company”), a late-stage clinical biopharmaceutical company focusing on the development and commercialization of a [...]

Obalon Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Full Year 2017

05/01/2018 - 14:00

SAN DIEGO, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ) today reported that it achieved preliminary, unaudited revenue of approximately $3.9 million for the fourth quarter ended December [...]

Molecular Templates Provides Corporate Update and Outlines 2018 Milestones

05/01/2018 - 14:00

Takeda Nominated Two Targets Under Research Collaboration in Dec. 2017 Updated MT-3724 Clinical Results Expected in 1H18 At Least Two New MTEM Products to Enter the Clinic in 2018 AUSTIN, Texas, Jan. 05, 2018 (GLOBE [...]

Aduro Biotech Announces Management Changes

05/01/2018 - 14:00

BERKELEY, Calif., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) a biopharmaceutical company with three distinct immunotherapy technologies, today announced that Jennifer Lew has been promoted to [...]

Retrophin and Censa Pharmaceuticals Enter into Strategic Collaboration to Advance CNSA-001 for the Treatment of Phenylketonuria (PKU)

05/01/2018 - 14:00

Retrophin obtains exclusive option to purchase Censa post proof-of-concept study Phase 2 proof-of-concept study in PKU patients expected to commence in mid-2018 SAN DIEGO, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Retrophin, [...]

Helius Medical Technologies Selects Key Tronic Corporation as its Commercial Contract Manufacturing Partner

05/01/2018 - 14:00

NEWTOWN, Pa., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”), a medical technology company focused on neurological wellness, [...]

Zealand Pharma to attend Oddo BHF Forum on January 12, 2018

05/01/2018 - 13:53

Press release - No. 1 / 2018 Zealand Pharma to attend Oddo BHF Forum on January 12, 2018 Copenhagen, 5 January, 2018 - Mats Blom, Executive Vice President and Chief Financial Officer (CFO) of Zealand Pharma, will be [...]

Biohit Oyj’s comments on its Chinese distributor’s announcement

05/01/2018 - 13:30

Biohit Oyj company release 5.1.2018 klo 14:30 local time (EEST) Biohit Oyj does not normally comment on its distributors or other third parties announcements, but due to details presented in the media and the potential [...]

ObsEva SA to Participate in JP Morgan Healthcare Conference January 8 - 11, 2018

05/01/2018 - 13:01

Geneva, Switzerland and Boston, MA - January 5, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]

miRagen Therapeutics Expands Board of Directors with Appointment of Arlene Morris

05/01/2018 - 13:00

BOULDER, Colo., Jan. 05, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced [...]

Idera Pharmaceuticals Provides 2018 Update and Outlook

05/01/2018 - 13:00

EXTON, Pa. and CAMBRIDGE, Mass., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of [...]

AxoGen to Participate at AAHS ASPN ASRM 2018 Annual Meetings

05/01/2018 - 13:00

ALACHUA, Fla., Jan. 05, 2018 (GLOBE NEWSWIRE) -- AxoGen Corporation (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerve damage, today announced its [...]

Surgery Partners Announces Appointment of Wayne S. DeVeydt as Chief Executive Officer

05/01/2018 - 13:00

NASHVILLE, Tenn., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) (the “Company”), a leading healthcare services company, today announced the appointment of Wayne S. DeVeydt as Chief Executive [...]

Axovant to Present at 36th Annual J.P. Morgan Healthcare Conference

05/01/2018 - 13:00

BASEL, Switzerland, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ: AXON ) today announced that its Chief Executive Officer David Hung, MD, will be presenting at the 36th Annual J.P. Morgan Healthcare [...]

Natus Appoints Leslie McDonnell as Vice President and General Manager of its Newborn Care Business Unit

05/01/2018 - 13:00

PLEASANTON, Calif., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) today announced it has named Leslie McDonnell as Vice President and General Manager of its Newborn Care Business Unit. Ms [...]